Skip to main content
. 2023 Jul 5;37:03946320231187759. doi: 10.1177/03946320231187759

Table 3.

The univariate and multivariate analyses results.

Overall survival Progression-free survival
Factor Univariate
p-value
Multivariate
p-value
HR Univariate
p-value
Multivariate
p-value
HR
Gender (male vs female) 0.24 0.34
Age group (<70 vs. ≥70 years) 0.20 0.49
ECOG (0–1 vs. 2) <0.001 0.008 1.96 0.002 0.011 1.78
Anemia (absent vs present) 0.016 0.024 1.64 0.032 0.036 1.52
T-stage (1–2 vs. 3–4) 0.009 0.017 1.42 0.004 0.007 1.51
N-stage (1 vs. 2–3) 0.006 0.009 1.63 0.002 0.005 1.74
PIV (<417 vs. ≥ 417) <0.001 <0.001 3.28 <0.001 <0.001 2.39

HR: hazard ratio; ECOG: eastern cooperative oncology group; T-stage: tumor stage, N-stage: nodal stage; PIV: pan-immune-inflammation value.